Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.

COUNTDOWN! HINJ to Host Life Sciences Celebration October 30; Four to Be Honored

hinj_logo_high_resNew Brunswick, NJ, October 28, 2015 ― The HealthCare Institute of New Jersey (HINJ) will honor meritorious leadership in and contributions to New Jersey’s life sciences community at its 2015 Life Sciences Celebration, which will be held Friday, October 30 at the Wyndham Garden Trenton from 8:00 to 10:00 a.m.

HINJ’s 2015 honorees will be:

  • The Honorable Bob Franks Public Service Award: Rep. Leonard Lance (R-7), Member, US House Energy and Commerce Committee
  • Research: Nils Lonberg, Ph.D., Senior Vice President, Oncology Discovery Biology, Bristol-Myers Squibb Company

In 2014, HINJ honored The Honorable Rush Holt, U.S. Representative (CD 12 – now retired); Joachim Kohn, Ph.D., FBSE, Director, New Jersey Center for Biomaterials, Board of Governors Professor of Chemistry, Rutgers; Students 2 Science, Inc.; and the Leukemia & Lymphoma Society – New Jersey Chapter.

At its inaugural Life Sciences Celebration, which was held September 25, 2013, HINJ recognized former Governor Thomas H. Kean; the late U.S. Senator Frank R. Lautenberg; Rutgers’ Dr. Christopher J. Molloy; Dr. Joseph R. Bertino of Rutgers Cancer Institute of New Jersey and Stem Cell Institute of New Jersey; Dr. Debra L. Wentz of New Jersey Association of Mental Health and Addiction Agencies (NJAMHAA); and Biotechnology High School.

To view a video from HINJ’s 2013 Celebration, click here.

To register for HINJ’s free 2015 Life Sciences Celebration, click here.

Founded in 1997, the HealthCare Institute of New Jersey (HINJ) serves as the voice for the state’s life sciences industry.  HINJ seeks to expand patient access to the most innovative biopharmaceuticals and medical devices and promote awareness of the industry’s impact on New Jersey’s quality of life and economic well-being.  In 2012, HINJ member companies’ economic impact in the state exceeded $26 billion, according to HINJ’s 2013 Economic Impact Report.

To learn more, please visit HINJ at www.hinj.org or follow us via Twitter @ HINJ_ORG, Facebook @ HealthCareInstituteofNewJersey, LinkedIn @HealthCareInstituteOfNewJersey or YouTube @HINJNJ.